Corrigendum to “The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia-reperfusion-induced renal fibrosis” [Int. Immunopharmacol. 132 (2024) 112002]

Saved in:
Bibliographic Details
Published inInternational immunopharmacology Vol. 147; p. 113963
Main Authors Wu, Huailiang, Wang, Liyan, Kang, Peng, Zhou, Xiangjun, Li, Wei, Xia, Zhongyuan
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 06.02.2025
Online AccessGet full text

Cover

Loading…
ArticleNumber 113963
Author Li, Wei
Wang, Liyan
Kang, Peng
Xia, Zhongyuan
Zhou, Xiangjun
Wu, Huailiang
Author_xml – sequence: 1
  givenname: Huailiang
  surname: Wu
  fullname: Wu, Huailiang
  organization: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan 430060, China
– sequence: 2
  givenname: Liyan
  surname: Wang
  fullname: Wang, Liyan
  organization: Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China
– sequence: 3
  givenname: Peng
  surname: Kang
  fullname: Kang, Peng
  organization: Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China
– sequence: 4
  givenname: Xiangjun
  surname: Zhou
  fullname: Zhou, Xiangjun
  organization: Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China
– sequence: 5
  givenname: Wei
  surname: Li
  fullname: Li, Wei
  organization: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan 430060, China
– sequence: 6
  givenname: Zhongyuan
  surname: Xia
  fullname: Xia, Zhongyuan
  email: xiazhongyuan2005@aliyun.com
  organization: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan 430060, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39799025$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAQx0VJaT7aNyhFx_Zgrz4sy74UwpK2CwspyfZQShGyJO_OspaN5C3JLQ-SPEXfKE8SLU57zGnEzG9m9J__KTryvXcIvackp4SWs20OfoRuyBlhRU4pr0v-Cp3QSlYZlUQcpbcoZSZkWR-j0xi3hKR8Qd-gY17LuiZMnKC_8z4EWDtv9x0ee_x4d7_aOHz9nc6uF1crOjufL3_iCGuvd-DXWN9AxJ2zoEcXcavH8RZrAxb3N2D1CL3H4HFwCccQzcZ1oLPgBhfafUzVDNIm4-wz0kIT-gjx8e4B_1r4MceLrtv7ftjo0GnT73JMOcMfDxo_YUoZIez3W_S61bvo3j3HM_Tjy8Vq_i1bXn5dzM-XmaGMi6wwjbC2sUQ2NWfSlLzVtSBlK6UjVVFQImpuLBGNNQVNtaq0WtCiKttGGFbxM_RhmjvsmyRZDQE6HW7Vv-sloJgAk0TE4Nr_CCXqYJLaqskkdRCgJpNS2-epzaXP_wEXVDTgfLoKBGdGZXt4ecATL_CdNw
ContentType Journal Article
Copyright 2024 Elsevier B.V.
Copyright_xml – notice: 2024 Elsevier B.V.
DBID AAYXX
CITATION
NPM
DOI 10.1016/j.intimp.2024.113963
DatabaseName CrossRef
PubMed
DatabaseTitle CrossRef
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1878-1705
ExternalDocumentID 39799025
10_1016_j_intimp_2024_113963
S1567576924024858
Genre Published Erratum
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AAXKI
AAXUO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACIWK
ACPRK
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AFJKZ
AFRAH
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJRQY
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
C45
CJTIS
CS3
DU5
EBS
EFJIC
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
IHE
J1W
KOM
L7B
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSI
SSP
SSZ
T5K
TEORI
UNMZH
~G-
.GJ
29J
53G
AAQXK
AATTM
AAYWO
AAYXX
ABFNM
ABWVN
ABXDB
ACIEU
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEUPX
AFPUW
AGCQF
AGQPQ
AGRNS
AI.
AIGII
AIIUN
AKBMS
AKYEP
APXCP
ASPBG
AVWKF
AZFZN
CITATION
EJD
FGOYB
HZ~
R2-
RIG
VH1
ZGI
AFKWA
AJOXV
AMFUW
NPM
ID FETCH-LOGICAL-c1235-4cb5ddbd07b9327c63fa9506f77e084410593cd05bdc41fa986da51486fb5c283
IEDL.DBID .~1
ISSN 1567-5769
IngestDate Wed Feb 19 02:02:18 EST 2025
Tue Jul 01 05:40:59 EDT 2025
Sat Mar 01 15:46:02 EST 2025
IsPeerReviewed true
IsScholarly true
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1235-4cb5ddbd07b9327c63fa9506f77e084410593cd05bdc41fa986da51486fb5c283
Notes erratum
PMID 39799025
ParticipantIDs pubmed_primary_39799025
crossref_primary_10_1016_j_intimp_2024_113963
elsevier_sciencedirect_doi_10_1016_j_intimp_2024_113963
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-Feb-06
PublicationDateYYYYMMDD 2025-02-06
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-Feb-06
  day: 06
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International immunopharmacology
PublicationTitleAlternate Int Immunopharmacol
PublicationYear 2025
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References 38608473 - Int Immunopharmacol. 2024 May 10;132:112002. doi: 10.1016/j.intimp.2024.112002
References_xml – reference: 38608473 - Int Immunopharmacol. 2024 May 10;132:112002. doi: 10.1016/j.intimp.2024.112002
SSID ssj0017041
Score 2.42826
SecondaryResourceType publication_corrigendum
SourceID pubmed
crossref
elsevier
SourceType Index Database
Publisher
StartPage 113963
Title Corrigendum to “The SP1/SIRT1/ACLY signaling axis mediates fatty acid oxidation in renal ischemia-reperfusion-induced renal fibrosis” [Int. Immunopharmacol. 132 (2024) 112002]
URI https://dx.doi.org/10.1016/j.intimp.2024.113963
https://www.ncbi.nlm.nih.gov/pubmed/39799025
Volume 147
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3batwwEBUhpdCX0qS3tGmYhxJaiNeXlS37cVkadnsJS3cDKaUY6wYqrL14vZB9KfmQ9iv6R_mSjiw7aZ8CfbUlW0jj0TnWnBlCXrNYahUWzOORYB7VAcNPCslKmiGb0DpSKrN6509nyeScvr-IL3bIuNfC2LDKzvc7n9566-6K382mvzLGnyPzYIiWM3s-QNPYCn4pZdbKBz9uwjxCFlCXMxUdgm3dy-faGC9TNmZps1ZG1BY3yZLhHdvTX3vP6SPysAONMHLj2iM7qtwn910Zye0-OZ65_NPbE1jcyqnWJ3AMs9vM1NvH5Pe4qmubflNultBUcH31EzvAfBb68-nnReiPxh-_gA3pKKxKHYpLs4ZWW4KAFHTRNFsohJFQXRpXiwlMCbWygzNIk9XSFF6tVqrWG_sXzkPCj6YjuyYaqXm1Nuvrq1_wdVo2A5hadUq16gc5AGSt8MZO1FtAiIZ-9NsTcn76bjGeeF3VBk9Y3a1HBY-l5DJgHLEhE8lQF1kcJJoxFaTUhpVmQyGDmEtBQ7yXJrJA2JYmmscC0c5TsltWpXpOALmWkDzWfKgz3DdVFsqIFtiacySKIjkgXr9Y-col58j7qLXvuVvc3I45d4t7QFi_ovk_Rpbj_nFHz2fOAG7e056HImB88d_PfEkeRLaYsA0BTw7JblNv1CtEOA0_ak34iNwbTT9Mzv4Ai4z8HA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3battAEF3SlNK-hDa9Jb3NQwktRJZkr7TSYzANdusEUzuQUorQ3mALlowsQ_xS8iHtV_SP8iWd1UpJ-xToq7QrLTujmXO0cyHkLYukVmHOPN4XzKM6YPhJIVlJUmQTWveVSm2-88lpPDqjH8-j8y0y7HJhbFhla_udTW-sdXvFb3fTXxrjz5B5METLqT0foEmU3CF3KX6-to1B78d1nEfIAuqKpqJFsMO7_LkmyMsUtVnYspV9arubpPHgFv_0l_M5fkh2WtQIR25hj8iWKnbJPddHcrNLDqauAPXmEOY3-VSrQziA6U1p6s1j8ntYVpWtvynXC6hLuLr8iRNgNg392fjzPPSPhpMvYGM6cpumDvmFWUGTXIKIFHRe1xvIhZFQXhjXjAlMAZWyizPIk9XC5F6llqrSa_sbzkPGj7oj2yEauXm5Mqury1_wdVzUPRjb9JRy2S2yB0hb4Z3dqPeAGA0N6bcn5Oz4w3w48tq2DZ6wibceFTySksuAcQSHTMQDnadREGvGVJBQG1eaDoQMIi4FDfFeEssccVsSax4JhDtPyXZRFuo5ASRbQvJI84FO0XGqNJR9muNozpEpiniPeJ2wsqWrzpF1YWvfMyfczK45c8LdI6yTaPaPlmXoQG6Z-cwpwPV7mgNRRIz7__3MN-T-aH4yySbj008vyIO-7Sxs48Hjl2S7rtbqFcKdmr9u1PkPQ5P9qg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corrigendum+to+%22The+SP1%2FSIRT1%2FACLY+signaling+axis+mediates+fatty+acid+oxidation+in+renal+ischemia-reperfusion-induced+renal+fibrosis%22+%5BInt.+Immunopharmacol.+132+%282024%29+112002%5D&rft.jtitle=International+immunopharmacology&rft.au=Wu%2C+Huailiang&rft.au=Wang%2C+Liyan&rft.au=Kang%2C+Peng&rft.au=Zhou%2C+Xiangjun&rft.date=2025-02-06&rft.eissn=1878-1705&rft.volume=147&rft.spage=113963&rft_id=info:doi/10.1016%2Fj.intimp.2024.113963&rft_id=info%3Apmid%2F39799025&rft.externalDocID=39799025
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-5769&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-5769&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-5769&client=summon